🇵🇹 Portugal Country × Condition
lymphoma Clinical Trials in Portugal
Active clinical trials for lymphoma with research sites in Portugal. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇵🇹 Portugal
Active Trials in Portugal (2)
NCT02332668 Phase 1, Phase 2
Recruiting
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Enrollment
370 pts
Country
🇵🇹 Portugal
Merck Sharp & Dohme LLC
View Trial → NCT05223413
Recruiting
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
Enrollment
608 pts
Country
🇵🇹 Portugal
Fundación Centro Nacional de Invest...
View Trial → Frequently Asked Questions
How many lymphoma clinical trials are active in Portugal?
There are currently 2 active clinical trials for lymphoma with sites in Portugal, of which 2 are actively recruiting patients.
How can I join a lymphoma clinical trial in Portugal?
To join a lymphoma clinical trial in Portugal, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Portugal directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are lymphoma trials in Portugal?
Active lymphoma trials in Portugal span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology